Biomarkers (3)
- OD_IGA - Optical density value as measured via ELISA for immunoglobulin A (phv00530505.v1.p1)
- OD_IGG - Optical density value as measured via ELISA for immunoglobulin G (phv00530504.v1.p1)
- OD_IGM - Optical density value as measured via ELISA for immunoglobulin M (phv00530506.v1.p1)
Demographics (3)
- AGE - Subject age at enrollment (phv00530502.v1.p1)
- SEX - Self-reported gender (phv00530501.v1.p1)
- SEX - Biological sex (phv00530496.v1.p1)
General Health (1)
- CPB - Undergone a cardiopulmonary bypass (CPB) (phv00530508.v1.p1)
Study Administration (2)
- COHORT - Distinguishing where cohort was recruited from (phv00530503.v1.p1)
- COHORT - Hospital from which subject was recruited (phv00530497.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte type (phv00530513.v1.p1)
- ANTIBODY_POSITIVE - PF4/heparin antibody positivity status based off of PF4/heparin-specific IgG optical density (OD_IGG) (phv00530832.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00530512.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00530495.v1.p1)
- HIPA_STATUS - Heparin-induced platelet activation status (phv00530507.v1.p1)
- IS_TUMOR - Tumor status of sample (phv00530514.v1.p1)
- SAMPLE_ID - Sample ID (phv00530511.v1.p1)
- SAMPLE_ID - Sample ID (phv00530499.v1.p1)
- SRA - Serotonin release assay (SRA) (phv00530509.v1.p1)
- SUBJECT_ID - Subject ID (phv00530500.v1.p1)
- SUBJECT_ID - Subject ID (phv00530494.v1.p1)
- SUBJECT_ID - Subject ID (phv00530498.v1.p1)
- UFH - Presence of unfractionated heparin (UFH) in heparin dosage (phv00530510.v1.p1)